Jennifer M. Rosenbluth

Author

Also Known As

J Rosenbluth, Jennifer M Rosenbluth, Jennifer M. Rosenbluth, Jennifer Margaret Rosenbluth, Jennifer Rosenbluth, Jennifer M. Rosenbluth, Laura J. van ‘t Veer

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Vanderbilt University Broad Institute

About

Jennifer M. Rosenbluth is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.5K
2	Engineering	1	1	60
3	Health Sciences	1	1	60
4	Biochemistry	1	1	190
5	Biostatistics	1	1	511

Jennifer M. Rosenbluth

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
A large peptidome dataset improves HLA class I epitope prediction across most of the human population Siranush Sarkizova, Susan Klaeger, Phuong M. Le, Nature Biotechnology HlaHistocompatibilityImmunogeneticsAutoimmune DiseaseHuman Leukocyte Antigen	2019	511
Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages Jennifer M. Rosenbluth, Ron C.J. Schackmann, G. Kenneth Gray, Nature Communications	2020	250
Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids Johanna F. Dekkers, Esmée J. van Vliet, Norman Sachs, Nature Protocols Breast Cancer OrganoidsLong-term CultureXenotransplantationDevelopmental BiologyMedicine	2021	240
Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing Carman Man-Chung Li, Hana Shapiro, Christina Tsiobikas, Cell Reports Systems BiologyDevelopmental BiologySingle-cell Rna SequencingSingle Cell SequencingMedicine	2020	196
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion Isaac S. Harris, Jennifer E. Endress, Jonathan L. Coloff, Cell Metabolism Reductive StressBiochemistryMedicineGlutathione DepletionCancer Cells	2019	190
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation Joshua A. Bauer, A. Bapsi Chakravarthy, Jennifer M. Rosenbluth, Clinical Cancer Research	2010	186
A human breast atlas integrating single-cell proteomics and transcriptomics G. Kenneth Gray, Carman Man-Chung Li, Jennifer M. Rosenbluth, Developmental Cell Human BreastFunctional GenomicsSingle Cell SequencingMedicineSingle-cell Genomics	2022	149
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67 Bojana Jovanović, Ingrid A. Mayer, Erica L. Mayer, Clinical Cancer Research	2017	145
p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network Clayton B. Marshall, Deborah J. Mays, J. Scott Beeler, Cell Reports Molecular RegulationGeneticsCell DeathMolecular GeneticsTranscriptional Regulation	2016	143
A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73 Jennifer M. Rosenbluth, Deborah J. Mays, Maria F. Pino, Molecular and Cellular Biology	2008	111

Page 1